Syndromes of Thrombotic Microangiopathy
- PMID: 28189178
- DOI: 10.1016/j.mcna.2016.09.010
Syndromes of Thrombotic Microangiopathy
Abstract
Thrombotic thrombocytopenia purpura (TTP) and the hemolytic uremic syndrome (HUS) are rare thrombotic microangiopathies that can be rapidly fatal. Although the acquired versions of TTP and HUS are generally highest on this broad differential, multiple rarer entities can produce a clinical picture similar to TTP/HUS, including microangiopathic hemolysis, renal failure, and neurologic compromise. More recent analysis has discovered a host of genetic factors that can produce microangiopathic hemolytic syndromes. This article discusses the current understanding of thrombotic microangiopathy and outlines the pathophysiology and causative agents associated with each distinct syndrome as well as the most accepted treatments.
Keywords: Atypical hemolytic uremic syndrome (aHUS); Hemolytic uremic syndrome (HUS); Microangiopathic hemolytic anemia (MAHA); Pregnancy induced microangiopathic hemolytic anemia; Thrombotic thrombocytopenic purpura (TTP); Transplant induced microangiopathic hemolytic anemia.
Published by Elsevier Inc.
Similar articles
-
Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).Am J Clin Pathol. 2016 Feb;145(2):158-65. doi: 10.1093/ajcp/aqv086. Am J Clin Pathol. 2016. PMID: 27124904 Review.
-
Thrombotic microangiopathies: from animal models to human disease and cure.Contrib Nephrol. 2011;169:337-350. doi: 10.1159/000314579. Epub 2011 Jan 20. Contrib Nephrol. 2011. PMID: 21252531
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.Nephrol Nurs J. 2002 Apr;29(2):171-80; quiz 181-2. Nephrol Nurs J. 2002. PMID: 11997952 Review.
-
Thrombotic microangiopathies (TTP, HUS, HELLP).Emerg Med Clin North Am. 2014 Aug;32(3):649-71. doi: 10.1016/j.emc.2014.04.008. Epub 2014 Jun 3. Emerg Med Clin North Am. 2014. PMID: 25060255 Review.
-
Pathophysiology and management of thrombotic microangiopathies.J Nephrol. 1998 Nov-Dec;11(6):300-10. J Nephrol. 1998. PMID: 10048496 Review.
Cited by
-
Navigating the Nexus: Lenalidomide-Associated Thrombotic Thrombocytopenic Purpura.Cureus. 2024 Jun 23;16(6):e62975. doi: 10.7759/cureus.62975. eCollection 2024 Jun. Cureus. 2024. PMID: 39050339 Free PMC article.
-
Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra.World J Transplant. 2024 Mar 18;14(1):90277. doi: 10.5500/wjt.v14.i1.90277. World J Transplant. 2024. PMID: 38576763 Free PMC article. Review.
-
Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer.Intern Med. 2024 Oct 1;63(19):2667-2671. doi: 10.2169/internalmedicine.2931-23. Epub 2024 Mar 4. Intern Med. 2024. PMID: 38432967 Free PMC article.
-
Beyond Immunosuppression: The Intricate Relationship Between Tacrolimus and Microangiopathy.Cureus. 2023 Nov 24;15(11):e49351. doi: 10.7759/cureus.49351. eCollection 2023 Nov. Cureus. 2023. PMID: 38146570 Free PMC article. Review.
-
Urinary exosomes: a promising biomarker of drug-induced nephrotoxicity.Front Med (Lausanne). 2023 Sep 22;10:1251839. doi: 10.3389/fmed.2023.1251839. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37809338 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
